Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Metabolic Newborn Screening Confirmation Panel Invitae United States | 201 | 158 |
|
Invitae United States | 466 | 297 |
|
PreventionGenetics, part of Exact Sciences United States | 36 | 27 |
|
Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum via the PEX26 Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 2 | 1 |
|
Panel of lysosomal disorders and mucopolysaccharidosis. NGS panel of 102 genes. Genologica Medica Spain | 175 | 102 |
|
Cholestasis panel. NGS panel of 46 genes. Genologica Medica Spain | 88 | 46 |
|
Peroxisomal disorders panel. NGS panel of 27 genes. Genologica Medica Spain | 45 | 27 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Peroxisomal Disorders Gene Panel Duzen Laboratories Duzen BBAGUAS Turkey | 39 | 30 |
|
PEX26 Deletion/duplication analysis Cincinnati Children's Hospital Medical Center Genetics and Genomics Diagnostic Laboratory Cincinnati Children's Hospital Medical Center United States | 2 | 1 |
|
Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 104 | 73 |
|
PEX26 Gene Sequencing by Massively Parallel Sequencing (BCM-NGSSM) Baylor Genetics United States | 1 | 1 |
|
PEX26 Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
PEX26 Sequence Analysis (Prenatal Sequence Analysis) Baylor Genetics United States | 1 | 1 |
|
Peroxisome biogenesis disorder: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 27 | 14 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 509 | 275 |
|
Fulgent Genetics United States | 9 | 5 |
|
Laboratorio de Genetica Clinica SL Spain | 6 | 6 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.